Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant mycobacterium tuberculosis in china

HIGHLIGHTS

• who: Hairong Huang and Hongfei Duan from the Chinese Center for Disease Control and Prevention, China Medical University, China have published the Article: Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China, in the Journal: (JOURNAL)
• what: The authors first compared the MICs of five oxazolidinones side by side against the reference strains of mycobacterial species and Mtb clinical isolates. The main reason for the above differences may due to the difference between the recruited isolates and the operation process of the MIC test.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.